Search Results - "Andrade de Mello, Ramon"

Refine Results
  1. 1

    The impact of polymorphic variations in the 5p15, 6p12, 6p21 and 15q25 Loci on the risk and prognosis of portuguese patients with non-small cell lung cancer by de Mello, Ramon Andrade, Ferreira, Mónica, Soares-Pires, Filipa, Costa, Sandra, Cunha, João, Oliveira, Pedro, Hespanhol, Venceslau, Reis, Rui Manuel

    Published in PloS one (06-09-2013)
    “…Polymorphic variants in the 5p15, 6p12, 6p21, and 15q25 loci were demonstrated to potentially contribute to lung cancer carcinogenesis. Therefore, this study…”
    Get full text
    Journal Article
  2. 2

    PD-L1 expression as a predictive biomarker in advanced non-small-cell lung cancer: updated survival data by Aguiar, Pedro N, De Mello, Ramon Andrade, Hall, Peter, Tadokoro, Hakaru, Lima Lopes, Gilberto de

    Published in Immunotherapy (01-05-2017)
    “…The treatment of non-small-cell lung cancer has changed after the development of the immune checkpoint inhibitors. Although the most studied biomarker is PD-L1…”
    Get full text
    Journal Article
  3. 3

    The role of PD-L1 expression as a predictive biomarker in advanced non-small-cell lung cancer: a network meta-analysis by Aguiar, Pedro N, Santoro, Ilka Lopes, Tadokoro, Hakaru, de Lima Lopes, Gilberto, Filardi, Bruno Andraus, Oliveira, Pedro, Mountzios, Giannis, de Mello, Ramon Andrade

    Published in Immunotherapy (01-04-2016)
    “…Tumor programmed death ligand one (PD-L1) expression has been studied in several trials in non-small-cell lung cancer. We assessed the potential role of PD-L1…”
    Get full text
    Journal Article
  4. 4

    Current and future trends in neoadjuvant immunotherapy for the treatment of triple-negative breast cancer by de Mello, Ramon Andrade, Perez, Kátia Roque, Vazquez, Thais Pérez

    Published in Immunotherapy (01-03-2024)
    “…Triple-negative breast cancer (TNBC) comprises 15-20% of all breast cancers (BC). Lacking targeted therapy options, TNBC becomes the focal point of clinical…”
    Get more information
    Journal Article
  5. 5

    Potential role of immunotherapy in advanced non-small-cell lung cancer by de Mello, Ramon Andrade, Veloso, Ana Flávia, Esrom Catarina, Paulo, Nadine, Sara, Antoniou, Georgios

    Published in OncoTargets and therapy (01-01-2017)
    “…Immuno checkpoint inhibitors have ushered in a new era with respect to the treatment of advanced non-small-cell lung cancer. Many patients are not suitable for…”
    Get full text
    Journal Article
  6. 6

    Cetuximab plus platinum-based chemotherapy in head and neck squamous cell carcinoma: a retrospective study in a single comprehensive European cancer institution by de Mello, Ramon Andrade, Gerós, Sandra, Alves, Marcos Pantarotto, Moreira, Filipa, Avezedo, Isabel, Dinis, José

    Published in PloS one (06-02-2014)
    “…The use of cetuximab in combination with platinum (P) plus 5-fluorouracil (F) has previously been demonstrated to be effective in the treatment of metastatic…”
    Get full text
    Journal Article
  7. 7

    Insights into angiogenesis in non-small cell lung cancer: molecular mechanisms, polymorphic genes, and targeted therapies by de Mello, Ramon Andrade, Costa, Bruno M, Reis, Rui M, Hespanhol, Venceslau

    “…Lung cancer is a highly prevalent disease worldwide. Currently, there are more than 150 million patients with lung cancer in the world, with more than 1…”
    Get more information
    Journal Article
  8. 8

    Targeting HER family in HER2-positive metastatic breast cancer: potential biomarkers and novel targeted therapies by de Paula Costa Monteiro, Inês, Madureira, Pedro, de Vasconscelos, Alessandro, Humberto Pozza, Daniel, Andrade de Mello, Ramon

    Published in Pharmacogenomics (01-03-2015)
    “…HER2-targeted therapies have radically changed the prognosis of HER2-positive breast cancer over the last few years. However, resistance to these therapies has…”
    Get full text
    Journal Article
  9. 9

    Are there, or shall we discover, biomarkers to guide PD-1 inhibition? by Ascierto, Paolo A, de Mello, Ramon Andrade

    Published in Immunotherapy (01-06-2016)
    “…Despite the recent success of PD-1/PD-L1-directed immunotherapy in a number of different malignancies, there are currently no effective biomarkers available to…”
    Get full text
    Journal Article
  10. 10

    Treatment Sequencing Strategies in Lung Cancer by Pozza, Daniel Humberto, Andrade de Mello, Ramon Bezerra

    Published in Zhongguo fei ai za zhi (20-05-2022)
    “…The advances in the lung cancer screening methods and therapeutics, together with awareness towards deleterious habits, such as smoking, is increasing the…”
    Get full text
    Journal Article
  11. 11

    Epidermal growth factor receptor and K-Ras in non-small cell lung cancer-molecular pathways involved and targeted therapies by de Mello, Ramon Andrade, Marques, Dânia Sofia, Medeiros, Rui, Araújo, António Mf

    Published in World journal of clinical oncology (10-11-2011)
    “…Lung cancer is currently the leading cause of cancer death in Western nations. Non-small cell lung cancer (NSCLC) represents 80% of all lung cancers, and…”
    Get full text
    Journal Article
  12. 12

    Current advances in targeted therapies for metastatic gastric cancer: improving patient care by Aguiar, Pedro Nazareth, Muniz, Thiago Pimentel, Miranda, Raelson Rodrigues, Tadokoro, Hakaru, Forones, Nora Manoukian, Monteiro, Ines-de-Paula, Castelo-Branco, Pedro, Janjigian, Yelena Y, de Mello, Ramon Andrade

    Published in Future Oncology (01-03-2016)
    “…In this article, we review the literature on the current advances in targeted therapies for metastatic gastric cancer aimed at improving patient care. We…”
    Get full text
    Journal Article Book Review
  13. 13

    Renal failure due to primary amyloidosis: a case report and literature review by de Mello, Ramon Andrade Bezerra, Marques Santos, Dania Sofia Neiva, Freitas-Silva, Margarida Paula Rebelo Nunes, Andrade, Joaquim Aguiar

    Published in São Paulo medical journal (01-05-2011)
    “…Primary amyloidosis, also known as AL amyloidosis, is commonly caused by clonal expansion of plasma cells in the bone marrow, thereby segregating light chains…”
    Get full text
    Journal Article
  14. 14
  15. 15

    CRISPR-based strategies in infectious disease diagnosis and therapy by Binnie, Alexandra, Fernandes, Emanuel, Almeida-Lousada, Helder, de Mello, Ramon Andrade, Castelo-Branco, Pedro

    Published in Infection (01-06-2021)
    “…Purpose CRISPR gene-editing technology has the potential to transform the diagnosis and treatment of infectious diseases, but most clinicians are unaware of…”
    Get full text
    Journal Article
  16. 16
  17. 17
  18. 18

    Update in Immunotherapy for Advanced Non-Small Cell Lung Cancer: Optimizing Treatment Sequencing and Identifying the Best Choices by Roque, Katia, Ruiz, Rossana, Mas, Luis, Pozza, Daniel Humberto, Vancini, Marina, Silva Júnior, José Antônio, de Mello, Ramon Andrade

    Published in Cancers (01-09-2023)
    “…The introduction of immunotherapy has brought about a paradigm shift in the management of advanced non-small cell lung cancer (NSCLC). It has not only…”
    Get full text
    Journal Article
  19. 19
  20. 20

    The impact of telemedicine on cancer care: real-world experience from a Peruvian institute during the COVID-19 pandemic by Roque, Katia, Ruiz, Rossana, Otoya-Fernandez, Iris, Galarreta, José, Vidaurre, Tatiana, de Mello, Ramon Andrade, Neciosup, Silvia, Mas, Luis, Gómez, Henry

    Published in Future oncology (London, England) (01-10-2022)
    “…The COVID-19 pandemic caused discontinuities in cancer care (CC) in most countries. Here, the authors describe the real-world impacts of implementing a…”
    Get full text
    Journal Article